Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer pulls sickle cell treatment Oxbryta
Sickle cell community scrambles to find safe plan after a drug is pulled from the market
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left scrambling to figure out what to do.
Pfizer withdraws sickle-cell disease treatment
U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks of a painful complication and deaths.
Pfizer to Withdraw Sickle-Cell Drug Oxbryta From Worldwide Markets
The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the approved sickle cell patient population.
Genentech’s cancer pivot, Pfizer’s sickle cell withdrawal, and a new schizophrenia drug
On STAT's Readout LOUD podcast, Jonathan Wosen talks about Genentech shutting down its cancer immunology team, and the ambitions of Chinese biotech Akeso.
Pfizer to pull sickle cell drug from market, shut down trials
The withdrawal comes as trial results indicate safety concerns with the drug, Oxbryta, which was first approved in the U.S. in 2019.
28m
Lifespan gets $1 million to improve sickle cell care
Papitto Opportunity Connection is hoping to help people struggling with a disease that it claims is "woefully understudied ...
14h
One woman's story brings new insight - and hope - to sickle cell disease
Patricia McGill is among the oldest people in the U.S. with sickle cell disease, and she attributes her longevity to optimism ...
2d
on MSN
Why gene therapy for sickle cell is slow to catch on with patients
Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...
4d
on MSN
Pfizer’s Strategy Looks Shakier After Sickle-Cell Disappointment
The company said it was withdrawing Oxbryta, a daily pill for patients with the disease, a serious, lifelong condition.
6h
on MSN
Sentara and EVMS to launch Comprehensive Sickle Cell Program
The program will bring specialists from hospital medicine, general medicine, psychiatry and pain medicine under one roof.
Baystate Health
9h
Comprehensive Guide to Sickle Cell Disease Symptoms and Treatment
Current sickle cell disease treatment options include: A cornerstone of SCD treatment since 1988, hydroxyurea works by increasing the production of hemoglobin F, which helps prevent the formation of ...
2d
A daily battle: Kamarie Crawford faces on-going fight with Sickle Cell
September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...
1d
Revolutionary sickle cell treatment providing hope and equity in action
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...
Opinion
11h
Opinion
Encourage voluntary blood donations to help battle Sickle Cell Disease
One such critical issue is India’s persistent blood shortage to meet the various needs of individuals, particularly in areas ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Pfizer
Oxbryta
Feedback